Pfizer/BioNTech COVID vaccine approved for use in older Australians The TGA has said there is ‘no specific risk’ associated with vaccinating older people, following reports of deaths in Norway.
Prime Minister reveals further $1.9 billion to support vaccine rollout General practice is expected to receive a substantial amount of the new allocation, but details remain limited.
Novavax confirms efficacy against emerging coronavirus variants New data on Australia’s third vaccine candidate shows it is highly effective against most COVID-19 variants, which may prove crucial as production bottlenecks force delays among other options.
COVID vaccine FAQs: What GPs need to know UPDATED: Prominent RACGP Fellow Dr Magdalena Simonis provides GPs with ready-made answers to help ease patients’ coronavirus concerns.
COVID vaccination EOIs give general practices ‘a seat at the table’ The RACGP is encouraging practices to submit their expression of interest, along with any concerns around the proposed delivery and funding model.
Will the new COVID vaccine ads help curb hesitancy? The $24 million campaign is aimed at reassuring Australians that the vaccines used in the rollout are safe and effective.
Opinion versus evidence: Searching for vaccine certainty Dr Natasha Yates examines the issue of navigating data, misinformation and vaccine hesitancy among patients and healthcare workers.
Pfizer COVID vaccine first to be approved in Australia The TGA has granted provisional approval ahead of next month’s planned rollout, which will now start in late February due to production delays.
Government seeks general practice EOIs for COVID vaccine rollout GPs will form the backbone of ‘one of the greatest logistical exercises’ in Australian history.
It’s crucial COVID vaccine hesitancy among health workers is addressed Deputy Chair for the Collaboration on Social Science and Immunisation Associate Professor Holly Seale reveals where to start.